Theralase Technologies Inc.
TSX VENTURE : TLT

Theralase Technologies Inc.

July 13, 2011 16:50 ET

Theralase Technologies Inc. to Hold Annual General Meeting on August 12, 2011

TORONTO, ONTARIO--(Marketwire - July 13, 2011) - Theralase Technologies Inc. (TSX VENTURE:TLT) announced today that it is holding its Annual General Meeting on Friday, August 12th, 2011 at 3:00pm EST at its offices located at 29 Gervais Drive, Suite 102, Toronto, Ontario. All shareholders of record as of July 13, 2011 are welcome to attend.

About Theralase Technologies Inc.

Theralase Technologies Inc. designs, develops, manufactures and markets patented, superpulsed laser technology utilized in biostimulation and biodestruction applications. The technology is safe and effective in the treatment of chronic pain, neural muscular-skeletal conditions and wound care. When combined with its patented, light-sensitive Photo Dynamic Compounds, Theralase laser technology is able to specifically target and destroy cancers, bacteria and viruses. For more information, visit www.theralase.com.

This press release may contain forward-looking statements which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual results could differ materially from those projected herein. The Company disclaims any obligation to update these forward-looking statements.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchanges) accepts responsibility for the adequacy or accuracy of this release.

Contact Information